Zobrazeno 1 - 8
of 8
pro vyhledávání: '"D Guerra-Estevez"'
Autor:
C Palomo-Palomo, D Guerra Estevez, MM Romero Alonso, A Parrado Gonzalez, M Reyes Malia, J Estaire Gutierrez
Publikováno v:
Section 4: Clinical pharmacy services.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M Perez-Perez, JJ Ramos-Báez, F Tellez-Perez, E Marquez-Fernandez, E Campos-Davila, P Villanueva, D Guerra-Estevez
Publikováno v:
European Journal of Hospital Pharmacy. 23:A42.2-A43
Background When both HIV and hepatitis C virus (HCV) treatments are indicated, the antiretroviral therapy (ART) may need to be modified before HCV treatment is initiated to reduce the potential for drug-drug interactions and overlapping toxicities th
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
E Campos-Davila, D Guerra-Estevez, E Marquez-Fernandez, G. Perez-Vazquez, JJ Ramos-Báez, J.L. Puerto-Alonso
Publikováno v:
European Journal of Hospital Pharmacy. 21:A145.3-A146
Background An association between sitagliptin and myopathy is exceptional, although four cases of rhabdomyolysis caused by a statin-sitagliptin interaction have been already reported, one of them with atorvastatin. Purpose To present a case of rhabdo
Autor:
JJ Ramos-Báez, E Campos-Davila, JL Prieto-García, F Tellez-Perez, D Guerra-Estevez, E Marquez-Fernandez
Publikováno v:
European Journal of Hospital Pharmacy. 21:A10.3-A11
Background In order to bring prescriptions for the use of direct-acting antiviral agents (DAAs) for the treatment of HCV genotype 1 infection in mono and co-infected patients in line with the recommendations of the Spanish Health System under the cur
Autor:
E Campos-Davila, G. Perez-Vazquez, D Guerra-Estevez, JJ Ramos-Báez, J.L. Puerto-Alonso, E Marquez-Fernandez
Publikováno v:
European Journal of Hospital Pharmacy. 21:A11.1-A11
Background According to current clinical guidelines developed from evidence-based medicine, heart failure with ventricular dysfunction needs to be treated with the combination of an ACE inhibitor and a beta blocker. An aldosterone antagonist should b
Publikováno v:
European Journal of Hospital Pharmacy. 21:A10.2-A10
Background The Andalusian Public Health Care Service have developed some indicators based on the selection of drugs for which there is better evidence of efficiency within several therapeutic groups, in areas of prescribing in which more deviations w